Dissecting the in vitro fate of plant-derived bioactive encapsulated nanoparticles in lung diseases

Bani Saeid, Ayeh; Patel, Vyoma K.; Mehndiratta, Samir; Rajput, Rashi; Kundu, Ramesh Kumar; Singh, Sachin Kumar; Chellappan, Dinesh Kumar; Kokkinis, Sofia; De Rubis, Gabriele; Collet, Trudi; Paudel, Keshav Raj; Hansbro, Philip Michael; Dua, Kamal

doi:10.1016/j.fbio.2023.103205

Food Bioscience

2023

DOI: 10.1016/j.fbio.2023.103205

|View full text |Cite

Dissecting the in vitro fate of plant-derived bioactive encapsulated nanoparticles in lung diseases

Ayeh Bani Saeid,

Vyoma K. Patel,

Samir Mehndiratta

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article4

Relationship

Self Cite0

Independent4

Authors

Journals

Cited by 4 publications

References 134 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Exploring Bioactive Phytomedicines for Advancing Pulmonary Infection Management: Insights and Future Prospects

Ho,

Ping,

Paudel

et al. 2024

Phytotherapy Research

View full text Add to dashboard Cite

Pulmonary infections have a profound influence on global mortality rates. Medicinal plants offer a promising approach to address this challenge, providing nontoxic alternatives with higher levels of public acceptance and compliance, particularly in regions where access to conventional medications or diagnostic resources may be limited. Understanding the pathophysiology of viruses and bacteria enables researchers to identify biomarkers essential for triggering diseases. This knowledge allows the discovery of biological molecules capable of either preventing or alleviating symptoms associated with these infections. In this review, medicinal plants that have an effect on COVID‐19, influenza A, bacterial and viral pneumonia, and tuberculosis are discussed. Drug delivery has been briefly discussed as well. It examines the effect of bioactive constituents of these plants and synthesizes findings from in vitro, in vivo, and clinical studies conducted over the past decade. In conclusion, many medicinal plants can be used to treat pulmonary infections, but further in‐depth studies are needed as most of the current studies are only at preliminary stages. Extensive investigation and clinical studies are warranted to fully elucidate their mechanisms of action and optimize their use in clinical practice.

show abstract

Exploring Bioactive Phytomedicines for Advancing Pulmonary Infection Management: Insights and Future Prospects

Ho,

Ping,

Paudel

et al. 2024

Phytotherapy Research

View full text Add to dashboard Cite

show abstract

Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders

Ashique,

Mishra,

Mantry

et al. 2024

Naunyn-Schmiedeberg's Arch Pharmacol

View full text Add to dashboard Cite

Involvement of osteopontin, EpCAM, estrogen receptor-alpha, and carbonic anhydrase IX protein in managing lung cancer via Berberine-loaded liquid crystalline nanoparticles

De Rubis,

Paudel,

Allam

et al. 2024

Pathology - Research and Practice

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Dissecting the in vitro fate of plant-derived bioactive encapsulated nanoparticles in lung diseases

Cited by 4 publications

References 134 publications

Exploring Bioactive Phytomedicines for Advancing Pulmonary Infection Management: Insights and Future Prospects

Exploring Bioactive Phytomedicines for Advancing Pulmonary Infection Management: Insights and Future Prospects

Crosstalk between ROS-inflammatory gene expression axis in the progression of lung disorders

Involvement of osteopontin, EpCAM, estrogen receptor-alpha, and carbonic anhydrase IX protein in managing lung cancer via Berberine-loaded liquid crystalline nanoparticles

Contact Info

Product

Resources

About